Clinical trials in Sevilla – page 36

1 637 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Sevilla at a glance

1 637

clinical trials

Research sites4

Quick filters

1 637 trials in Sevilla

Open in trial search

BRAF V600E mutation positive+1

Recruiting

Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

Registered drugNo placebo

Study on the Effectiveness and Safety of Plixorafenib (FORE8394) for Patients with Cancer Having BRAF Alterations

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cobicistat
Sponsor:Fore Biotherapeutics Inc.

Contact Research Centre

Plasma cell myeloma

Recruiting

Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo

Study on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Hdp-101
Sponsor:Heidelberg Pharma AG

Contact Research Centre

Factor VIII deficiency

Recruiting

Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

Registered drugNo placebo

Study on Emicizumab and Drug Combination for Patients with Haemophilia A and FVIII Inhibitors

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Emicizumab
Sponsor:Emory University

Contact Research Centre

Squamous cell carcinoma of lung+2

Recruiting

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:OSE Immunotherapeutics

Contact Research Centre

Seizure

Recruiting

Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Study on the Safety and Effectiveness of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Investigational

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Alprazolam
Sponsor:UCB Biopharma

Contact Research Centre

Duchenne muscular dystrophy

Recruiting

Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

InvestigationalNo placebo

Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

InvestigationalNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Givinostat
Sponsor:Italfarmaco S.p.A.

Contact Research Centre

HER2 gene amplification

Recruiting

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Zongertinib
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Sarcoidosis

Recruiting

Study of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis

Registered drug

Study of XTMAB-16 and Prednisolone Sodium Phosphate for Patients with Pulmonary Sarcoidosis

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Xtmab-16
Sponsor:Xentria Inc.

Contact Research Centre

Relapsing-remitting multiple sclerosis

Recruiting

Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

Registered drug

Study Comparing the Effects of Ozanimod and Fingolimod in Children and Adolescents with Relapsing Remitting Multiple Sclerosis

Registered drug

Spain

Participants:0–17 years
Substances:Fingolimod
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Migraine

Recruiting

Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

Registered drug

Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

Registered drug

Spain

Participants:0–17 years
Substances:Eptinezumab
Sponsor:H. Lundbeck A/S

Contact Research Centre

Medulloblastoma

Recruiting

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years
Substances:Carboplatin
Sponsor:University Medical Center Hamburg-Eppendorf

Contact Research Centre

Bronchopulmonary dysplasia

Recruiting

Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

InvestigationalNo placebo

Safety Study of Mesenchymal Cells for Preterm Infants with Bronchopulmonary Dysplasia

InvestigationalNo placebo

Spain

Participants:0–17 years
Substances:Mesenchymal Cells
Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Sevilla

What the registry says about research in the country

01 Metabolic and Endocrine Disorders

Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.

Diabetes Management
Obesity Treatment
Metabolic Disorders

Studies aim to improve treatment outcomes for patients with complex metabolic conditions.

02 Neurological Conditions

Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.

Multiple Sclerosis Therapies
Neurodegenerative Diseases
Brain Health Innovation

Research focuses on developing targeted treatments for various neurological conditions.

03 Infectious Diseases

Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.

Vaccine Development
Viral Infections
Immunization Studies

Studies aim to enhance vaccine efficacy and immune response across different age groups.

04 Oncology Research

Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.

Cancer Immunotherapy
Targeted Therapies
Combination Treatments

Focus on developing innovative approaches to improve cancer treatment outcomes.

05 Autoimmune Conditions

Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.

Arthritis Treatment
Inflammatory Diseases
Immune System Disorders

Research aims to develop more effective treatments for chronic autoimmune conditions.

Back to Spain All countries